Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Europe
|
US/Canada
|
Japan
|
Asia (excluding Japan)
|
Latin America
|
Rest of World
|
International - US/CANADA
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
KV unit Ethex pleads guilty to two felonies in oversize pill case
09 March 2010
KV Pharmaceutical unit Ethex Corp pled guilty on March 2nd in the US District Court for the Eastern District of Missouri to two felonies in connection with the manufacturing of oversized prescription drug tablets, according to the US Justice ...
US court tosses out FTC's challenge to alleged "pay-for-delay" Androgel settlement
26 February 2010
A US federal judge has thrown out a Federal Trade Commission antitrust lawsuit alleging that Abbott Laboratories' Solvay unit conspired with generic drug makers to delay competition for its testosterone supplement Androgel. Judge Thomas Thrash of ...
Basilea and J&J terminate Zeftera deal after CHMP negative opinion
22 February 2010
The EU's CHMP has refused to endorse the approval of Basilea Pharmaceutica 's intravenous broad-spectrum cephalosporin antibiotic Zeftera (ceftobiprole) for the treatment of complicated skin and skin structure infections. The decision has prompted ...
Fall in Adderall sales rolls into Shire's Q4
19 February 2010
Generic competition for Shire Pharmaceuticals ' largest selling product, Adderall XR, has pushed sales of the attention-deficit hyperactivity disorder (ADHD) treatment into a nine-month slump. Although price increases in the fourth-quarter removed ...
Billy Tauzin to step down from PhRMA amid uncertainty in US healthcare reform
15 February 2010
Billy Tauzin , who for the past five years has been the influential leader of the powerful US pharmaceutical industry body, PhRMA , is to step down as president on June 30th to explore "many other interests". Mr Tauzin will remain as president ...
 
2010 Scrip 100 - Rich pickings for biosimilars?
09 December 2009
While the US, Europe and Japan each get to grips with the challenges posed by off-patent biologics, the debate has now turned to the global stage. Ian Schofield reports. Europe may have blazed the ...
2010 Scrip 100 - Stem cell trials, tribulations and trailblazers
09 December 2009
The prospects of true innovation have lured companies of all sizes into the stem cell space. The strategies being implemented by research groups are diverse and colourful, yet the regulatory terrain ...
2010 Scrip 100 - David Brennan juggling pharma and PhRMA
09 December 2009
It was never going to be a quiet year for David Brennan . A slowing pipeline, neutral ratings from analysts and a recession were among the challenges that AstraZeneca's CEO addressed in 2009. Now ...
 
Interview: European Medicines Agency gets serious about its global strategy
29 January 2010
Developing relationships with medicine regulators in China and India is just one of the challenges facing Emer Cooke, the international face of the European Medicines Agency (EMA), Scrip's Elizabeth ...
 
Commentary: US CDC should protest against Gardasil fear-mongering
20 July 2009
Merck & Co and the US Centers for Disease Control and Prevention ( CDC ) face a challenge – how to counter emotionally charged reports in the US lay media questioning the safety of the cervical ...
Commentary: Ebullient over Effient, depressed over Daschle
04 February 2009
The atmosphere after a US FDA advisory panel meeting can be sedate and gloomy for sponsor pharmaceutical companies if the agency's outside experts take a negative view on their drug applications. But ...
US post-election buzz: a tale of stem cells, trade agreements and power struggles
12 November 2008
One week after US voters elected Illinois Democratic senator Barack Obama as their next president, we offer a few interesting post-election titbits on which Scrip's Washington bureau is keeping an ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm